Printer-friendly version
Helicoll™ is a bioengineered high purity type I collagen membrane. Acellular bioactive skin substitute is bioresorbable to facilitate tissue regeneration for wound management. Flexible and translucent with moderate tackiness.
• Granulation in four to five days
• Helps reduce pain
• Rehydrates in saline solution in five minutes
• Can be used with negative pressure wound therapy
• Priced to be used inpatient as well as outpatient
• Collagen fibrils are organized in a parallel pattern similar to that of native tissue fibrillar structure
• Porosity is approximately 20μ to attract more cells/regenerative factors
• Patented process yields high purity type-I bovine collagen (>97% homologous to human type I collagen) allowing for biocompatibility
Helicoll™ is indicated for use on diabetic ulcers, pressure injuries, venous ulcers, draining wounds with slit openings, partial- or full-thickness wounds, tunneling or undermined wounds, surgical wounds (i.e., donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric or wound dehiscence) and trauma wounds (i.e., abrasions, lacerations, second-degree burns or skin tears).
3 year shelf life at room temperature
Bovine type-I collagen
| Assigned HCPCS code | ● |
| Dehydrated | |
| Desiccated | |
| Flowable | |
| Micronized | |
| Sheet form | ● |
| Requires refrigeration | |
| Shelf life greater than 2 years | ● |
| Shelf life limited | |
| Indicated for acute wounds | ● |
| Indicated for chronic wounds | ● |
| Indicated for diabetic ulcers | ● |
| Indicated for pressure ulcers | ● |
| Indicated for second-degree burns | |
| Indicated for surgical wounds | ● |
| Indicated for third-degree burns | |
| Indicated for venous ulcers | ● |
| Contact manufacturer for usage guidelines |
| Educational Material Available | ● |
| Free Samples/Trials Available | |
| Published Clinical Article Available | ● |
Acute Wounds
Chronic Wounds
Deep Wounds Wounds
Dehisced Wounds
Diabetic Foot
Granulating/Epitheliasing Wounds
Hypertrophic Scars/Keloids
Infected Wounds
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Palliative Wounds
Pressure Ulcers
Sloughy Wounds
Superficial Wounds
Surgical Wounds
Venous Ulcers
Remove Helicoll™ from package and separate first the clear polymer sheet. Soak in sterile saline for approximately for five to ten minutes and remove the other white polymer sheet also. Apply Helicoll™ over the debrided wound bed and remove any trapped air bubbles. In surgical settings, Helicoll™ can be retained in place using tape, suture or staples. Refer to the Helicoll™ application guide to apply a non-adherent porous dressing sheet over Helicoll™ and for the secondary compressive dressing applications. Leave Helicoll™ in place for five to seven days, unless any complication or infection arises. Prophylactic antibiotic may be used as the doctor prefers. Helicoll™ will absorb into the wound bed. Make slits with a surgical scalpel if needed when exudate is present.
Removal of a Helicoll™ membrane is not required except when wound is infected or if excessive exudate is under the Helicoll™ membrane. For slowly healing chronic wounds, it may be changed after five to seven days.
Apply every 7 days as needed.
EnColl Corporation is a California corporation that develops, manufactures and markets type I collagen-based products.